RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 Short- and Long-Term Efficacy of Tofacitinib in the Treatment of Patients with RA and an Inadequate Response to TNF Inhibitors
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 19
SP 18
OP 18
DO 10.1177/155989771219014
UL http://mdc.sagepub.com/content/12/19/18.1.abstract
AB Treatment with the oral Janus kinase (JAK) inhibitor tofacitinib was associated with an improvement in the signs and symptoms of rheumatoid arthritis (RA), physical function, and patient reported outcomes in RA patients with an inadequate response to tumor necrosis factor inhibitors (TNFi). The improved response was maintained over 24 months.